DIABEGONE Trademark

Trademark Overview

On Monday, March 27, 2017, a trademark application was filed for DIABEGONE with the United States Patent and Trademark Office. The USPTO has given the DIABEGONE trademark a serial number of 87386119. The federal status of this trademark filing is REGISTERED as of Tuesday, August 20, 2019. This trademark is owned by KUNMING INNOGEN PHARMACEUTICAL TECHNOLOGY CO., LTD.. The DIABEGONE trademark is filed in the Pharmaceutical Products category with the following description:

Anti-diabetic pharmaceuticals; Medicinal preparations for treatment of diabetes; Pharmaceutical preparations and substances for the treatment of diabetes, obesity and metabolic diseases; Pharmaceutical preparations for the treatment and prevention of diabetes; Pharmaceutical preparations for the treatment of diabetes and obesity
diabegone

General Information

Serial Number87386119
Word MarkDIABEGONE
Filing DateMonday, March 27, 2017
Status700 - REGISTERED
Status DateTuesday, August 20, 2019
Registration Number5840138
Registration DateTuesday, August 20, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 1, 2017

Trademark Statements

Goods and ServicesAnti-diabetic pharmaceuticals; Medicinal preparations for treatment of diabetes; Pharmaceutical preparations and substances for the treatment of diabetes, obesity and metabolic diseases; Pharmaceutical preparations for the treatment and prevention of diabetes; Pharmaceutical preparations for the treatment of diabetes and obesity

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 30, 2017
Primary Code005
First Use Anywhere DateWednesday, March 15, 2017
First Use In Commerce DateTuesday, February 6, 2018

Trademark Owner History

Party NameKUNMING INNOGEN PHARMACEUTICAL TECHNOLOGY CO., LTD.
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressKUNMING CITY, YUNNAN PROVINCE 650106
CN
Party NameNOT AVAILABLE
Party Type30 - Original Registrant
Legal Entity Type01 - Individual
AddressNorth York M2H3L3
CA
Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressNorth York M2H3L3
CA
Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressNorth York M2H3L3
CA

Trademark Events

Event DateEvent Description
Wednesday, January 20, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, December 24, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, December 24, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 24, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 24, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 24, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 20, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, July 17, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 16, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, June 19, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 19, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 13, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 12, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 12, 2019NON-FINAL ACTION E-MAILED
Wednesday, June 12, 2019SU - NON-FINAL ACTION - WRITTEN
Tuesday, May 21, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 21, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, May 19, 2019ASSIGNED TO LIE
Saturday, May 11, 2019TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sunday, April 28, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 13, 2018NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, November 13, 2018FINAL REFUSAL E-MAILED
Tuesday, November 13, 2018SU - FINAL REFUSAL - WRITTEN
Monday, October 22, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 22, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 22, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 24, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 24, 2018NON-FINAL ACTION E-MAILED
Tuesday, April 24, 2018SU - NON-FINAL ACTION - WRITTEN
Tuesday, April 3, 2018STATEMENT OF USE PROCESSING COMPLETE
Wednesday, March 14, 2018USE AMENDMENT FILED
Monday, April 2, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 14, 2018TEAS STATEMENT OF USE RECEIVED
Tuesday, September 26, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 1, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 1, 2017PUBLISHED FOR OPPOSITION
Wednesday, July 12, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 21, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 20, 2017ASSIGNED TO EXAMINER
Thursday, March 30, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 30, 2017NEW APPLICATION ENTERED

Related Keywords

diabegone treatment preparations diabetes pharmaceutical obesity metabolic prevention diseases substances diabetic